Analytical testing of mycotoxins using HPLC-MSMS
Innovative analytical testing service for mycotoxins using HPLC-MSMS, offering both quantitative multi-mycotoxin screens and single mycotoxin analysis. Validated against lateral flow techniques, this service ensures accuracy and reliability in food safety testing.
Overview
The analytical testing service for mycotoxins offered by Campden BRI utilizes high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MSMS) to deliver precise quantitative multi-mycotoxin screens. Additionally, it provides options for single mycotoxin analysis through HPLC-UV/FLD or ELISA methods. This service is designed to enhance food safety by ensuring accurate detection and quantification of mycotoxins in various matrices, which is critical for maintaining quality standards in the food industry.
Technical specifications
Key features:
- Utilizes HPLC-MSMS technology for comprehensive multi-mycotoxin screening.
- Offers single mycotoxin analysis using HPLC-UV/FLD or ELISA techniques.
- Validates methods against lateral flow results to ensure high accuracy.
- Matrix-specific validation includes assessments of linearity, spike recoveries, accuracy, repeatability, and reproducibility.
- Measures key parameters such as Limit of Detection, Limit of Quantification, and Measurement of Uncertainty.
Technology readiness level
The technology is at TRL 6, indicating it has been thoroughly validated with matrix-specific standards and is ready for further refinement and broader implementation in commercial settings.
About Campden BRI
Campden BRI is an independent, membership‑based research and technology organization serving the global food and drink sector, with its main site in Chipping Campden and additional operations in Surrey and Budapest. Industry access is built into the model: co‑located UKAS‑accredited laboratories, extensive pilot‑scale processing halls, and a dedicated consumer test centre enable confidential, end‑to‑end problem solving and scale‑up with rapid turnaround. Member companies shape a shared research agenda while also commissioning proprietary projects, training, and regulatory guidance through established contractual frameworks. Work is supported by a mix of member‑funded programs, fee‑for‑service contracts, and selected publicly funded collaborations. Clear IP and confidentiality arrangements support commercialization and implementation with partners.
delivered to your inbox.